Dolby Laboratories (DLB) is a Industrials company in the Specialty Business Services industry. It has a market capitalization of $6.07B, a trailing price-to-earnings ratio of 15.8 and a free-cash-flow yield of 6.8%. Over the most recent reported fiscal year, revenue grew 5.9% and free cash flow per share grew 44.5%. Nama's AI scorecard rates it Buy, 7.0 out of 10. On 12-month momentum it ranks in the lagging band of its market.
AI scorecard
Buy · 7.0/10
Positive, at the low end of Buy. As of Nov 7, 2026.
Momentum
Lagging · -10.2% over 12 months ex. last
Second-worst fifth of its market on the past year's move.
Shariah screen
Shariah Compliant
Passes our debt, cash and income screen; not a scholar's ruling.
Off its high
-33.1%
How far the last close sits under the highest price of the past five years.
Market cap
$6.07B
Trailing P/E
15.8
Price / book
2.4
Price / sales
4.5
FCF yield
6.8%
Dividend yield
2.2%
Gross margin
87.6%
Operating margin
12.6%
Net margin
16.7%
Revenue growth (YoY)
+5.9%
Revenue growth (3-yr annual)
+2.5%
EPS growth (YoY)
+11.8%
FCF/share growth (YoY)
+44.5%
Beta
0.8
Exchange
NYSE
Sector
Industrials
Industry
Specialty Business Services
DLB earnings
Next report: Nov 17, 2026 (Q4 2026, EPS estimate $1.20).
Beat the EPS estimate in 4 of 4 recent quarters.
Quarter
Reported
EPS
Estimate
Surprise
Revenue
Q3 2026
Jul 30, 2026
$0.69
$0.67
+3.0%
$305.00M
Q2 2026
Apr 30, 2026
$1.37
$1.34
+2.2%
$395.63M
Q1 2026
Jan 29, 2026
$1.06
$0.99
+7.1%
$346.71M
Q4 2025
Nov 18, 2025
$0.99
$0.71
+39.4%
$307.02M
DLB analyst price target
Median target $85.00 from 3 analysts, ranging $62.00 – $90.00.
Nama's AI scorecard currently rates Dolby Laboratories Buy (7.0 out of 10), a call computed from its profitability, cash generation, growth, valuation and balance sheet. It is a research reading, not investment advice.
What is DLB's P/E ratio?
Dolby Laboratories trades at a trailing price-to-earnings ratio of 15.8.
When does DLB report earnings?
Dolby Laboratories's next scheduled report is on Nov 17, 2026. Analysts expect EPS of $1.20.
What is the DLB price target?
The median analyst price target from 3 analysts is $85.00, with a range of $62.00 – $90.00.
Is DLB Shariah compliant?
Nama's AAOIFI-style screen reads Dolby Laboratories as Shariah Compliant. Passes our debt, cash and income screen; not a scholar's ruling.
Does DLB pay a dividend?
Yes — Dolby Laboratories's dividend yield is 2.2%.